What Researchers Did
Researchers conducted a prospective matched case-control study involving 58 Type 2 diabetic patients to investigate changes in lipoprotein subfractions after hyperbaric oxygen therapy.
What They Found
In 31 patients receiving hyperbaric oxygen therapy, researchers observed decreased subfractions of VLDL, IDL 3, LDL 1, LDL 2, and LDL 3-7. Additionally, the IDL 1 subfraction and C-peptide concentration significantly increased, and glycemic variability improved, while no such changes were seen in the 27 control patients.
What This Means for Canadian Patients
Hyperbaric oxygen therapy may offer a potential benefit for Canadian patients with Type 2 diabetes by improving lipoprotein profiles and glycemic control. These changes could potentially reduce the risk of atherosclerosis and related cardiovascular complications in this patient population.
Canadian Relevance
This study was not conducted in Canada and does not have a direct Canadian connection.
Study Limitations
The study's relatively small sample size and short follow-up period limit the generalizability and long-term implications of these findings.